Analog sensitive chemical inhibition of the DEAD‐box protein DDX3. (26th December 2015)

• Record Type: Journal Article
• Authors: Floor, Stephen N.; Barkovich, Krister J.; Condon, Kendall J.; Shokat, Kevan M.; Doudna, Jennifer A.
• Is Part Of: Protein science. Volume 25:Number 3(2016:Mar.)
• Page Start: 638
• Page End: 649
• Publication Date: 2015-12-26
• Subjects: chemical genetics -- DEAD‐box proteins -- small‐molecule inhibitor -- RNA -- protein engineering -- DDX3 inhibitor; Proteins -- Periodicals; 572.6
• DOI: 10.1002/pro.2857
• Languages: English
• ISSNs: 0961-8368

Abstract

Abstract: Proper maintenance of RNA structure and dynamics is essential to maintain cellular health. Multiple families of RNA chaperones exist in cells to modulate RNA structure, RNA–protein complexes, and RNA granules. The largest of these families is the DEAD‐box proteins, named after their catalytic Asp‐Glu‐Ala‐Asp motif. The human DEAD‐box protein DDX3 is implicated in diverse biological processes including translation initiation and is mutated in numerous cancers. Like many DEAD‐box proteins, DDX3 is essential to cellular health and exhibits dosage sensitivity, such that both decreases and increases in protein levels can be lethal. Therefore, chemical inhibition would be an ideal tool to probe the function of DDX3. However, most DEAD‐box protein active sites are extremely similar, complicating the design of specific inhibitors. Here, we show that a chemical genetic approach best characterized in protein kinases, known as analog‐sensitive chemical inhibition, is viable for DDX3 and possibly other DEAD‐box proteins. We present an expanded active‐site mutant that is tolerated in vitro and in vivo, and is sensitive to chemical inhibition by a novel bulky inhibitor. Our results highlight a course towards analog sensitive chemical inhibition of DDX3 and potentially the entire DEAD‐box protein family.